A detailed history of Gsa Capital Partners LLP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 11,047 shares of HBIO stock, worth $23,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,047
Holding current value
$23,198
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$2.64 - $3.54 $29,164 - $39,106
11,047 New
11,047 $30,000
Q1 2023

May 12, 2023

SELL
$2.45 - $4.22 $214,316 - $369,148
-87,476 Reduced 75.85%
27,854 $116,000
Q4 2022

Feb 13, 2023

BUY
$2.12 - $2.86 $79,529 - $107,290
37,514 Added 48.21%
115,330 $319,000
Q3 2022

Nov 14, 2022

BUY
$2.33 - $3.92 $181,311 - $305,038
77,816 New
77,816 $199,000
Q1 2021

May 10, 2021

SELL
$3.91 - $6.99 $226,310 - $404,581
-57,880 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$3.0 - $4.5 $30,912 - $46,368
10,304 Added 21.66%
57,880 $248,000
Q3 2020

Nov 06, 2020

BUY
$2.75 - $4.2 $130,834 - $199,819
47,576 New
47,576 $143,000
Q1 2020

May 12, 2020

SELL
$1.42 - $3.29 $22,712 - $52,623
-15,995 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$2.45 - $3.25 $1,225 - $1,625
-500 Reduced 3.03%
15,995 $49,000
Q3 2019

Nov 12, 2019

SELL
$1.59 - $3.47 $55,650 - $121,450
-35,000 Reduced 67.97%
16,495 $51,000
Q2 2019

Aug 06, 2019

SELL
$1.93 - $4.59 $248,317 - $590,558
-128,662 Reduced 71.42%
51,495 $103,000
Q1 2019

May 15, 2019

SELL
$2.77 - $4.38 $31,855 - $50,370
-11,500 Reduced 6.0%
180,157 $776,000
Q4 2018

Feb 12, 2019

BUY
$3.03 - $5.0 $29,087 - $48,000
9,600 Added 5.27%
191,657 $609,000
Q3 2018

Nov 13, 2018

BUY
$5.0 - $6.65 $33,500 - $44,555
6,700 Added 3.82%
182,057 $956,000
Q2 2018

Aug 09, 2018

SELL
$4.2 - $5.95 $8,400 - $11,900
-2,000 Reduced 1.13%
175,357 $938,000
Q1 2018

May 11, 2018

SELL
$3.3 - $5.15 $61,050 - $95,275
-18,500 Reduced 9.45%
177,357 $887,000
Q4 2017

Feb 14, 2018

SELL
$3.08 - $3.8 $50,696 - $62,548
-16,460 Reduced 7.75%
195,857 $646,000
Q3 2017

Nov 20, 2017

BUY
$2.7 - $3.75 $573,255 - $796,188
212,317
212,317 $796,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $87.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.